Sale!

Ganglioside Antibody Profile IgM Test

940 د.إ

-10%

The Ganglioside Antibody Profile IgM Test is a specialized diagnostic procedure aimed at detecting the presence of IgM antibodies against gangliosides in the blood. Gangliosides are complex glycosphingolipids present in the cell membranes, especially within the nervous system. The presence of these antibodies can be indicative of autoimmune disorders, particularly those affecting the nervous system such as Guillain-Barré syndrome, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy, among others.

This test is crucial for patients presenting symptoms of neurological disorders, as it helps in the differential diagnosis and guiding the appropriate treatment strategy. The process involves a blood sample drawn from the patient, which is then analyzed in the laboratory for the presence of IgM class antibodies against various gangliosides.

At DNA Labs UAE, the Ganglioside Antibody Profile IgM Test is available for 940 AED. The lab is equipped with state-of-the-art technology to ensure accurate and reliable results. It is recommended for individuals who have symptoms suggestive of autoimmune neuropathies or for those under investigation for unexplained neurological conditions. The cost of the test includes the collection of the sample, the analysis, and a comprehensive report of the findings.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GANGLIOSIDE ANTIBODY PROFILE IgM Test

Cost: AED 940.0

Overview

The Ganglioside Antibody Profile IgM test is a blood test that measures the levels of specific antibodies called IgM antibodies against gangliosides. Gangliosides are a type of glycolipid found on the surface of nerve cells. This test is primarily used to diagnose certain autoimmune disorders that affect the peripheral nerves, such as Guillain-Barre syndrome and Miller Fisher syndrome.

Components

  • GM1
  • GM2
  • GM3
  • GD1a
  • GD1b
  • GT1b
  • GQ1b

Price

AED 940.0

Sample Condition

2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.

Report Delivery

Sample Tue by 9 am; Report Same day

Method

Immunoblot

Test Type

Disorders of Nervous System

Doctor

Neurologist

Test Department

Pre Test Information

No special preparation required

Test Details

The Ganglioside Antibody Profile IgM test is a blood test that measures the levels of specific antibodies called IgM antibodies against gangliosides. Gangliosides are a type of glycolipid found on the surface of nerve cells. This test is primarily used to diagnose certain autoimmune disorders that affect the peripheral nerves, such as Guillain-Barre syndrome and Miller Fisher syndrome. These disorders occur when the body’s immune system mistakenly attacks the gangliosides, leading to inflammation and damage to the nerves.

The Ganglioside Antibody Profile IgM test helps to identify the specific gangliosides that are being targeted by the immune system. The test measures the levels of IgM antibodies against different types of gangliosides, including GM1, GD1a, GD1b, and GQ1b. Elevated levels of IgM antibodies against gangliosides may indicate an autoimmune neuropathy, while normal levels usually rule out these conditions. However, it’s important to note that a positive test result does not necessarily confirm the diagnosis, as other factors such as clinical symptoms and other test results are also taken into consideration.

The Ganglioside Antibody Profile IgM test is typically ordered by a healthcare provider if a person presents with symptoms suggestive of autoimmune neuropathy, such as muscle weakness, numbness or tingling in the limbs, difficulty walking, or problems with coordination. The test involves taking a blood sample from the patient, which is then sent to a laboratory for analysis. Results are usually available within a few days.

It’s important to discuss the test results with a healthcare provider, who can provide a proper interpretation and guide further diagnostic and treatment decisions.

Test Name GANGLIOSIDE ANTIBODY PROFILE IgM Test
Components *GM1*GM2*GM3*GD1a*GD1b*GT1b *GQ1b
Price 940.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST. Ship refrigeratedor frozen.
Report Delivery SampleTue by 9 am; Report Same day
Method Immunoblot
Test type Disorders of Nervous System
Doctor Neurologist
Test Department:
Pre Test Information No special preparation required
Test Details

The Ganglioside Antibody Profile IgM test is a blood test that measures the levels of specific antibodies called IgM antibodies against gangliosides. Gangliosides are a type of glycolipid found on the surface of nerve cells.

This test is primarily used to diagnose certain autoimmune disorders that affect the peripheral nerves, such as Guillain-Barre syndrome and Miller Fisher syndrome. These disorders occur when the body’s immune system mistakenly attacks the gangliosides, leading to inflammation and damage to the nerves.

The Ganglioside Antibody Profile IgM test helps to identify the specific gangliosides that are being targeted by the immune system. The test measures the levels of IgM antibodies against different types of gangliosides, including GM1, GD1a, GD1b, and GQ1b.

Elevated levels of IgM antibodies against gangliosides may indicate an autoimmune neuropathy, while normal levels usually rule out these conditions. However, it’s important to note that a positive test result does not necessarily confirm the diagnosis, as other factors such as clinical symptoms and other test results are also taken into consideration.

The Ganglioside Antibody Profile IgM test is typically ordered by a healthcare provider if a person presents with symptoms suggestive of autoimmune neuropathy, such as muscle weakness, numbness or tingling in the limbs, difficulty walking, or problems with coordination.

The test involves taking a blood sample from the patient, which is then sent to a laboratory for analysis. Results are usually available within a few days.

It’s important to discuss the test results with a healthcare provider, who can provide a proper interpretation and guide further diagnostic and treatment decisions.